Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


Articles published in Ophthalmology

Retrieve available abstracts of 18 articles:
HTML format



Single Articles


    March 2024
  1. NIAZI S, Gnesin F, Thein AS, Andreasen JR, et al
    Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.
    Ophthalmology. 2024 Mar 8:S0161-6420(24)00171.
    PubMed     Abstract available


    February 2024
  2. JHAVERI CD, Liu D, Maguire MG, Glassman AR, et al
    Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity <20/40.
    Ophthalmology. 2024 Feb 7:S0161-6420(24)00098.
    PubMed     Abstract available


  3. WU Y, Egan C, Olvera-Barrios A, Scheppke L, et al
    Developing a Continuous Severity Scale for Macular Telangiectasia Type 2 Using Deep Learning and Implications for Disease Grading.
    Ophthalmology. 2024;131:219-226.
    PubMed     Abstract available


    January 2024
  4. SAMMONS EL, Buck G, Bowman LJ, Stevens WM, et al
    ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
    Ophthalmology. 2024 Jan 16:S0161-6420(24)00056.
    PubMed     Abstract available


  5. CHAUHAN MZ, Elhusseiny AM, Kishor KS, Sanvicente CT, et al
    Association of Primary Open-Angle Glaucoma with Diabetic Retinopathy Among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study.
    Ophthalmology. 2024 Jan 10:S0161-6420(24)00052.
    PubMed     Abstract available


    December 2023
  6. WONG TY, Haskova Z, Asik K, Baumal CR, et al
    Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
    Ophthalmology. 2023 Dec 27:S0161-6420(23)00933.
    PubMed     Abstract available


  7. SAMMONS EL, Buck G, Bowman LJ, Stevens WM, et al
    ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy.
    Ophthalmology. 2023 Dec 3:S0161-6420(23)00870.
    PubMed     Abstract available


  8. EHRLICH JR, Andes LJ, Eisenberg A, Saaddine J, et al
    Trends in the Diagnosed Prevalence and Incidence of Major Eye Diseases in Medicare Part B Fee-for-Service Beneficiaries 68 Years of Age or Older.
    Ophthalmology. 2023;130:1240-1247.
    PubMed     Abstract available


    June 2023
  9. TACCHERI C, Jordan J, Tran D, Wang J, et al
    The impact of social determinants of health on eye care utilization in a national sample of people with diabetes.
    Ophthalmology. 2023 Jun 15:S0161-6420(23)00425.
    PubMed     Abstract available


    March 2023
  10. REGILLO C, Berger B, Brooks L, Clark WL, et al
    Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
    Ophthalmology. 2023 Mar 2:S0161-6420(23)00135.
    PubMed     Abstract available


    February 2023
  11. SHAKARCHI AF, Soliman MK, Yang YC, Sallam AB, et al
    Risk of Pseudophakic Cystoid Macular Edema in Fellow-Eye Cataract Surgeries: A Multicenter Database Study.
    Ophthalmology. 2023 Feb 3:S0161-6420(23)00063.
    PubMed     Abstract available


    December 2022
  12. BAKER CW, Josic K, Maguire MG, Jampol LM, et al
    Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to eETDRS Protocol Visual Acuity Assessment.
    Ophthalmology. 2022 Dec 12:S0161-6420(22)00976.
    PubMed     Abstract available


    August 2022
  13. LOIS N, Campbell C, Waugh N, Azuara-Blanco A, et al
    DIAbetic Macular Oedema aNd Diode Subthreshold micropulse laser (DIAMONDS): A randomized double-masked non-inferiority clinical trial.
    Ophthalmology. 2022 Aug 13. pii: S0161-6420(22)00631.
    PubMed     Abstract available


  14. CHIA MA, Taylor JR, Stuart KV, Khawaja AP, et al
    Prevalence of diabetic retinopathy in Indigenous and non-Indigenous Australians: a systematic review and meta-analysis.
    Ophthalmology. 2022 Aug 2. pii: S0161-6420(22)00566.
    PubMed     Abstract available


    May 2022
  15. MELLES RB, Marmor MF
    Rapid Macular Thinning is an Early Indicator of Hydroxychloroquine Retinal Toxicity.
    Ophthalmology. 2022 May 11. pii: S0161-6420(22)00335.
    PubMed     Abstract available


    January 2022
  16. SINGER MA, Sheth V, Mansour SE, Coughlin B, et al
    Three-year safety and efficacy of the 0.19-mg fluocinolone acetonide intravitreal implant for diabetic macular edema: the PALADIN study.
    Ophthalmology. 2022 Jan 18. pii: S0161-6420(22)00067.
    PubMed     Abstract available


    October 2021
  17. GONZALEZ VH, Wang PW, Ruiz CQ
    Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials: Not "1 and Done".
    Ophthalmology. 2021;128:1448-1457.
    PubMed     Abstract available


    June 2021
  18. LENG T, Gallivan MD, Kras A, Lum F, et al
    Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes-an IRIS Registry Study.
    Ophthalmology. 2021 Jun 15. pii: S0161-6420(21)00455.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.